These studies suggest that APT-weighted imaging is beneficial in distinguishing PCNSL from IDH wild-type glioblastoma, advocating for its use in suspected PCNSL cases to avoid unnecessary aggressive surgical resection, thereby improving the accuracy of differential diagnoses. The gene discussed is IDH1; the disease is primary central nervous system lymphoma.